| Afshine A Emrani, MD | |
|
18370 Burbank Blvd, 401, Tarzana, CA 91356-2804 | |
| (818) 996-4100 | |
| (818) 996-0842 |
| Full Name | Afshine A Emrani |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 31 Years |
| Location | 18370 Burbank Blvd, Tarzana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356360887 | NPI | - | NPPES |
| 00G80597R | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | G80597 (California) | Primary |
| 207R00000X | Internal Medicine | G80597 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedars-sinai Medical Center | Los angeles, CA | Hospital |
| West Hills Hospital & Medical Center | West hills, CA | Hospital |
| Providence Tarzana Medical Center | Tarzana, CA | Hospital |
| Entity Name | Los Angeles Heart Specialist Medical Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194750679 PECOS PAC ID: 4284696600 Enrollment ID: O20041028000624 |
News Archive
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
FotoFinder presents advanced devices for early skin cancer detection at the World Congress of Dermoscopy in Brisbane from May 17 to 19. The new mobile and stationary devices offer better diagnostic accuracy for doctors and more safety for patients. Latest development is the connection of a mobile dermatoscope for iPhone with an online webspace where doctors can request a second opinion on suspicious moles.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Afshine A Emrani, MD 18370 Burbank Blvd, 401, Tarzana, CA 91356-2804 Ph: (818) 996-4100 | Afshine A Emrani, MD 18370 Burbank Blvd, 401, Tarzana, CA 91356-2804 Ph: (818) 996-4100 |
News Archive
Insilico Medicine, a Baltimore-based company specializing in the application of next-generation artificial intelligence for drug discovery, biomarker development and aging research, announces the presentation of its CEO, Alex Zhavoronkov, at the Pioneers 18 Conference, May 25, 2018, Vienna, Austria.
FotoFinder presents advanced devices for early skin cancer detection at the World Congress of Dermoscopy in Brisbane from May 17 to 19. The new mobile and stationary devices offer better diagnostic accuracy for doctors and more safety for patients. Latest development is the connection of a mobile dermatoscope for iPhone with an online webspace where doctors can request a second opinion on suspicious moles.
Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that starting April 1, 2010 physicians are able to send FNA cell block samples to Rosetta Genomics' CLIA-certified and CAP-accredited laboratory in Philadelphia for analysis using Rosetta's miRview squamous test. FNA is a less invasive method to obtain tumor cells compared with tumor resections or biopsies.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments based on Pleotherapy for severe neurological diseases, today announced that it has put together a €2.5 million round of financing (corresponding to a pre-money company valuation of €60 million).
› Verified 4 days ago
Ryan Matthew Ponec, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18133 Ventura Blvd Ste 300, Tarzana, CA 91356 Phone: 818-981-3818 | |
Dr. Jeffrey Philip Salberg, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18370 Burbank Blvd, Ste 601, Tarzana, CA 91356 Phone: 818-996-5700 Fax: 818-996-1649 | |
Dr. Jeffrey Work, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18370 Burbank Blvd, Suite 707, Tarzana, CA 91356 Phone: 818-345-5580 Fax: 818-774-0458 | |
Alan Fozailoff, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18370 Burbank Blvd, Suite 211, Tarzana, CA 91356 Phone: 818-334-5750 Fax: 951-272-9924 | |
Dr. Yehuda Handelsman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18372 Clark St, Suite 212, Tarzana, CA 91356 Phone: 818-708-9942 Fax: 818-708-0154 | |
Dr. Richard C Wong, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18370 Burbank Blvd, Suite 707, Tarzana, CA 91356 Phone: 818-345-5580 Fax: 818-774-0458 | |
Dr. Mark L Geller, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 18133 Ventura Blvd, Suite 204, Tarzana, CA 91356 Phone: 818-466-7700 Fax: 818-996-1649 |